Arca
Skip to content
Tools
Tools

Grace Therapeutics, Inc.

4 private offerings reported to the SEC on Form D since 2016, $32.9M sold in all. Pharma, New Jersey.

  • Form D offerings: 4
  • Reported sold: $32.9M
  • Newest: Aug 11, 2026
  • FDA records: Company page

Every Form D offering

Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
Aug 11, 2026—$10.0M$10.0MGrace Therapeutics, Inc.Pharma · New JerseyNot amended0001123292-26-001084
Feb 25, 2025—$15.0M$30.0MGrace Therapeutics, Inc.Biotech · New JerseyNot amended0001140361-25-005827
Oct 10, 2023—$7.5M$15.1MAcasti Pharma Inc.Biotech · Quebec, CanadaNot amended0001123292-23-000122
May 25, 2018—$373K$838KAcasti Pharma Inc.Biotech · Quebec, CanadaNot amended0001209191-18-033239

SEC Profile

From the company's EDGAR record
Ticker
GRCE
Business address
Princeton, NJ
Incorporated in
Delaware
SEC industry
Pharmaceutical Preparations
Former names
Acasti Pharma Inc.
All SEC filings
CIK 1444192 on EDGAR

A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.